We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The test “offers an alternative to lab-developed tests or analyte-specific reagent combinations, potentially minimizing variability and complexity in testing,” Roche said. Read More
“The new technologies being funded … have the potential to transform the diagnostics landscape if their promise is proven in clinical studies,” said HHS Assistant Secretary for Health Brett Giroir. Read More
Yeliva is currently in mid-to-late stage testing globally for hospitalized patients with severe COVID-19 pneumonia who require supplemental oxygen. Read More